1 study on Azd1402 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
The low immunogenicity profile of AZD1402 (Elarekibep) is a critical finding, as it significantly reduces the risk of immune-mediated adverse events and potential loss of drug efficacy over time. This data provides st…